Supporting Families Through Induction of Labor: Evidence, Expectations, and Options

By Birth & Baby University · Last updated: October 2026 · 4 min read

Induction is common, and families receive it in different ways: as a medical recommendation, a scheduling offer or a choice at 39 or 41 weeks. The evidence has shifted over the last decade, but it varies by population and question. This article summarizes the main trials and what they mean for the conversations doulas have.

Key takeaways

• The ARRIVE trial of low-risk first-time parents found no significant difference in its composite perinatal outcome with induction at 39 weeks, and a lower cesarean rate (18.6 percent versus 22.2 percent).
• The 2020 Cochrane review found fewer perinatal deaths with a policy of induction at or beyond 37 weeks (high-certainty), though absolute rates are small (0.4 versus 3 per 1,000).
• The SWEPIS trial found no difference in its composite outcome between induction at 41 weeks and waiting until 42, but stopped early because of more perinatal deaths in the waiting group.
• Induction is a choice for many low-risk pregnancies. Different clinicians and hospitals may offer it at different times.

What the research says

Induction at 39 weeks

In the ARRIVE trial, 6,106 low-risk first-time pregnant people at 38 weeks were randomized to induction at 39 weeks or expectant management. The primary composite of perinatal death or severe neonatal complication occurred in 4.3 percent versus 5.4 percent (RR 0.80, 95% CI 0.64 to 1.00), not a statistically significant difference. Cesarean was significantly lower with induction (RR 0.84, 95% CI 0.76 to 0.93). The trial applies to low-risk first-time parents in participating U.S. centers, and expectant management in the control group could still end in induction later.

The broader evidence

The 2020 Cochrane review included 34 trials and over 21,000 women and infants, mostly in high-income settings, comparing a policy of induction (usually after 41 weeks) with waiting. Induction was associated with fewer perinatal deaths (RR 0.31, 95% CI 0.15 to 0.64; four deaths versus 25; number needed to treat 544), fewer stillbirths, lower cesarean rates without more operative vaginal births, and fewer NICU admissions. Subgroup analyses found no differences by timing, parity or cervical state for main outcomes. The authors noted that childhood neurodevelopment was not reported, that the optimal timing needs further research and that tailored counselling helps people choose.

41 versus 42 weeks

The SWEPIS trial randomized 2,760 low-risk women in Sweden to induction at 41 weeks or expectant management with induction at 42. The primary composite did not differ (2.4 percent versus 2.2 percent), but six perinatal deaths occurred in the expectant group and none in the induction group, so the study stopped early. Cesarean, instrumental birth and maternal morbidity did not differ. A 2025 Swedish register cohort study after the national shift to more active management from 41 weeks reported lower peri/neonatal death (adjusted RR 0.52, 95% CI 0.38 to 0.69) and a small rise in emergency cesarean (adjusted RR 1.07). Because it is observational and lacks data on fetal monitoring, it shows associations, not proof.

Methods

The 2025 ACOG Clinical Practice Guideline No. 9 on cervical ripening covers term, singleton, vertex pregnancies with intact membranes. It recommends pharmacologic, mechanical or combination methods (strong recommendation, high-quality evidence); suggests combining pharmacologic and mechanical methods to shorten the time from admission to delivery in appropriate candidates (conditional, high-quality evidence); recommends either oral or vaginal misoprostol, says vaginal dinoprostone may be used, and recommends mechanical methods; and suggests that outpatient ripening is a safe and effective way to reduce time from admission to delivery in low-risk patients (conditional, high-quality evidence). It does not apply to pregnancies outside those criteria. Which method, dose and setting a person is offered is a clinical decision; doulas can help families ask why a method was chosen and what the plan is if it does not work.

What this means for doulas

• Do not frame induction as good or bad. Trials suggest benefits in some low-risk populations, and individual circumstances matter. Many inductions are medically indicated for reasons these trials excluded.
• Prepare for a long process. Cervical ripening can take time. Set expectations that induction may start slowly, and plan for rest, food and comfort measures that fit the unit’s rules.
• Help clients ask questions. Why now, what method, what are the alternatives, what if we wait, what monitoring will there be and what happens if it does not work.
• Respect the decision either way. Declining or accepting are both within a person’s right to informed choice.

Putting the evidence into practice

• Offer a question list that clients can take to appointments and use when induction is raised.
• Explain the main phases (ripening, starting contractions, active labor) and that the process varies.
• Plan the practical side: packing, childcare, who will be present, how to sleep if ripening happens overnight.
• Maintain nonjudgmental language and support grief or disappointment when a hoped-for spontaneous start does not happen.

The bottom line

Trials support offering induction at or after 39 to 41 weeks for many low-risk pregnancies, with small absolute benefits and tradeoffs. Doulas support families with accurate information, good questions and practical help, leaving timing and method to the clinical team.

This article is for professional education. It is not medical, legal or tax advice. Check the standards of your certifying organization and the rules where you work.

Sources and further reading

• Grobman WA, et al. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. New England Journal of Medicine 2018. Read the source
• Middleton P, et al. Induction of labour at or beyond 37 weeks’ gestation. Cochrane Database of Systematic Reviews 2020. Read the source
• Wennerholm UB, et al. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial. BMJ 2019. Read the source
• Kallen K, et al. Maternal and perinatal outcomes after implementation of a more active management in late- and postterm pregnancies in Sweden: a population-based cohort study. PLoS Medicine 2025. Read the source
• ACOG Committee on Clinical Practice Guidelines-Obstetrics. Cervical Ripening in Pregnancy: ACOG Clinical Practice Guideline No. 9. Obstetrics & Gynecology 2025. Read the source

Supporting families through changed plans is a core doula skill. See the birth doula training and mentorship options on the For Doulas page.

More for professionals: the Professionals Blog.